Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $165.5 million.

  • Xeris Biopharma Holdings' Shares Outstanding rose 1108.99% to $165.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.5 million, marking a year-over-year increase of 1108.99%. This contributed to the annual value of $149.4 million for FY2024, which is 817.97% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Shares Outstanding stood at $165.5 million for Q3 2025, which was up 1108.99% from $161.2 million recorded in Q2 2025.
  • Over the past 5 years, Xeris Biopharma Holdings' Shares Outstanding peaked at $165.5 million during Q3 2025, and registered a low of $66.3 million during Q1 2021.
  • Over the past 5 years, Xeris Biopharma Holdings' median Shares Outstanding value was $138.0 million (recorded in 2023), while the average stood at $131.5 million.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Shares Outstanding soared by 10947.96% in 2021 and then skyrocketed by 130.09% in 2023.
  • Xeris Biopharma Holdings' Shares Outstanding (Quarter) stood at $124.9 million in 2021, then rose by 9.13% to $136.3 million in 2022, then increased by 1.36% to $138.1 million in 2023, then increased by 8.18% to $149.4 million in 2024, then increased by 10.77% to $165.5 million in 2025.
  • Its last three reported values are $165.5 million in Q3 2025, $161.2 million for Q2 2025, and $156.0 million during Q1 2025.